AICAR showed biological activity in human cells by selective inhibition of growth of BRCA1-deficient HCC1937 breast carcinoma cells, BRCA1-deficient BCR-ABL1-positive leukemia cells, and BRCA2-deficient Capan-1 pancreatic adenocarcinoma cells. This evidence concerns the gene BRCA2 and leukemia.